Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Drug News & Perspectives|March 5, 2009
Cannabinoid receptors as therapeutic targets in the management of liver diseasesAriane Mallat, Sophie LotersztajnAmerican Journal of Physiology. Cell Physiology|August 2, 2013
Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosisAriane Mallat, Sophie LotersztajnJournal of Hepatology|February 19, 2008
Environmental factors as disease accelerators during chronic hepatitis CAriane Mallat, Christophe Hezode, Sophie LotersztajnJournal of Hepatology|April 10, 2013
Cannabinoid signaling and liver therapeuticsAriane Mallat, Fatima Teixeira-Clerc, Sophie LotersztajnJournal of Hepatology|February 25, 2021
Targeting cell-intrinsic metabolism for antifibrotic therapyHelene Gilgenkrantz, Ariane Mallat, Richard Moreau, et al.The Journal of Biological Chemistry|July 26, 2002
Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblastsJulien Davaille, Liying Li, Ariane Mallat, et al.Expert Opinion on Therapeutic Targets|February 15, 2007
Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseasesAriane Mallat, Fatima Teixeira-Clerc, Vanessa Deveaux, et al.Annual Review of Pharmacology and Toxicology|October 9, 2004
Hepatic fibrosis: molecular mechanisms and drug targetsSophie Lotersztajn, Boris Julien, Fatima Teixeira-Clerc, et al.Journal of Hepatology|September 1, 2004
Molecular mechanisms regulating the antifibrogenic protein heme-oxygenase-1 in human hepatic myofibroblastsLiying Li, Boris Julien, Pascale Grenard, et al.Biomed Research International|September 26, 2014
Autophagy: a multifaceted partner in liver fibrosisAriane Mallat, Jasper Lodder, Fatima Teixeira-Clerc, et al.Pageof 7